Results 81 to 90 of about 221,174 (192)

Meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine: a new conjugate vaccine against invasive meningococcal disease

open access: yesInfection and Drug Resistance, 2014
Carine P Hedari,* Rima W Khinkarly,* Ghassan S Dbaibo Center for Infectious Diseases Research, Division of Pediatric Infectious Diseases, Department of Pediatrics and Adolescent Medicine, American University of Beirut Medical Center, Beirut, Lebanon ...
Hedari CP, Khinkarly RW, Dbaibo GS
doaj  

Meningococcal disease. Meningococcal conjugate polysaccharide vaccines and new generation vaccines. Report 3

open access: yesБиопрепараты: Профилактика, диагностика, лечение, 2018
Despite the progress in fighting against infectious diseases of bacterial origin, the incidence of generalized forms of meningococcal infection (GFMI) remains a topical public health problem not only in countries with historical high incidence, but also ...
M. V. Abramtseva   +2 more
doaj  

Immunogenicity and safety of meningococcal vaccines, MenACWY-CRM and 4CMenB, in groups at increased risk for meningococcal disease

open access: yesExpert Review of Vaccines
Introduction Individuals with immunocompromising conditions (e.g. asplenia, complement deficiency, HIV infection) or with high exposure to Neisseria meningitidis (e.g.
Shravani Bobde   +3 more
doaj   +1 more source

How the Knowledge of Interactions between Meningococcus and the Human Immune System Has Been Used to Prepare Effective Neisseria meningitidis Vaccines

open access: yesJournal of Immunology Research, 2015
In the last decades, tremendous advancement in dissecting the mechanisms of pathogenicity of Neisseria meningitidis at a molecular level has been achieved, exploiting converging approaches of different disciplines, ranging from pathology to microbiology,
R. Gasparini   +7 more
doaj   +1 more source

Efficacy and Safety of Quadrivalent Conjugate Meningococcal Vaccines: A Systematic Review and Meta-Analysis. [PDF]

open access: yesVaccines (Basel), 2023
Conti A   +5 more
europepmc   +1 more source

Social Behavior and Meningococcal Carriage in British Teenagers

open access: yes, 2006
Understanding predisposing factors for meningococcal carriage may identify targets for public health interventions. Before mass vaccination with meningococcal group C conjugate vaccine began in autumn 1999, we took pharyngeal swabs from ?14,000 UK ...
MacLennan, J.   +43 more
core   +2 more sources

Evaluating the Impact of Meningococcal Vaccines With Synthetic Controls. [PDF]

open access: yesAm J Epidemiol, 2022
Prunas O   +4 more
europepmc   +1 more source

Impact of meningococcal group B OMV vaccines, beyond their brief

open access: yesHuman Vaccines & Immunotherapeutics, 2018
Meningococcal group B outer membrane vesicle vaccines have been used widely in Cuba, New Zealand, and Brazil. They are immunogenic and initially assessed largely by their ability to induce serum bactericidal activity.
Helen Petousis-Harris
doaj   +1 more source

Home - About - Disclaimer - Privacy